Cargando…

Thoracic sarcopenia as a predictive factor of SARS-COV2 evolution

PURPOSE: Evaluation of CT sarcopenia as a predictor of intensive care hospitalization during SARS-COV2 infection. MATERIALS AND METHODS: Single-center retrospective study of patients admitted to hospital with SARS-COV2 infection. The estimation of muscle mass (skeletal muscle index (SMI)) for sarcop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koehler, J., Boirie, Y., Bensid, L., Pereira, B., Ghelis, N., Dupuis, C., Tournadre, A., Boyer, L., Cassagnes, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801230/ https://www.ncbi.nlm.nih.gov/pubmed/35140034 http://dx.doi.org/10.1016/j.clnu.2022.01.022

Ejemplares similares

Thoracic sarcopenia as a predictive factor of SARS-COV2 outcomes
por: Koehler, J., et al.
Publicado: (2021)

Predicting SARS-CoV-2 Asymptomatic Infection Rate of Inpatients: A Time Series Analysis
por: Rivera, Frida, et al.
Publicado: (2021)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Nutritional status in post SARS-Cov2 rehabilitation patients
por: Gobbi, M., et al.
Publicado: (2022)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

The HIV and SARS-CoV-2 Parallel in Dentistry from the Perspectives of the Oral Health Care Team
por: Brondani, M., et al.
Publicado: (2020)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Association of nitrogen balance trajectories with clinical outcomes in critically ill COVID-19 patients: A retrospective cohort study
por: Dupuis, Claire, et al.
Publicado: (2022)

Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
por: Newell, Krista L., et al.
Publicado: (2022)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries
por: Verberk, Janneke D. M., et al.
Publicado: (2022)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
por: Bordejé Laguna, Luisa, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
por: Ng, Siew C, et al.
Publicado: (2022)

SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report
por: Bulut, Haldun, et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Corticosteroids and Other Treatments Administered to Children Tested for SARS-CoV-2 Infection in Emergency Departments
por: Freedman, Stephen B., et al.
Publicado: (2022)

New daily persistent headache after SARS-CoV-2 infection: a report of two cases
por: Dono, Fedele, et al.
Publicado: (2021)

Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study
por: Weber, Sabine, et al.
Publicado: (2021)

Low thoracic skeletal muscle index is associated with negative outcomes in 244 patients with respiratory COVID-19
por: Grigioni, S., et al.
Publicado: (2023)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t712mqsc9ect3h8t77sn1dfr17